Citation: | GUO Wei, XIE Chunwen, WANG Wensheng, ZHENG Deqiang, HE Shuwang. Synthesis of related substances of tebipenem pivoxil[J]. Journal of China Pharmaceutical University, 2018, 49(3): 286-290. DOI: 10.11665/j.issn.1000-5048.20180305 |
[1] |
Kumagai T,Tamai S,Abe T,et al.Current status of oral carbapenem development[J].J Curr Med Chem,2001,1(1):1-14.
|
[2] |
Peng DM,Li YX,Liu YF,et al.Study on the synthesis of tebipenem pivoxil[J].Chin J Antibio(中国抗生素杂志),2013,38(1):41-58.
|
[3] |
Shi Y,Zhang YR,Zhou FG,et al.Improved synthesis of tebipenem pivoxil[J].Chin J Med Chem(中国药物化学杂志),2011,21(5):383-385.
|
[4] |
Hu YJ,Chen DK,Tao FR,et al.In vitro activities of tebipenem pivoxil against clinical isolates[J].Chin J Clin Pharmacol(中国临床药理学杂志),2012,28(12):950-954.
|
[5] |
Zhai X,Sui Q,Shi HL.Graphical synthetic routes of tebipenem pivoxil[J].Chin J Pharm(中国医药工业杂志),2012,43(6):503-506.
|
[6] |
Mizera M,Talaczyńska A,Zalewski P,et al.Prediction of HPLC retention times of tebipenem pivoxyl and its degradation products in solid state by applying adaptive artificial neural network with recursive features elimination[J].Talanta,2015,137:174-181.
|
[7] |
Cielecka-Piontek J,Zalewski P,Barszcz B,et al.Stress degradation studies of tebipenem and a validated stability-indicating LC method[J].Chromatographia,2013,76(7/8):381-386.
|